- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cap-Ex Ventures Ltd. (TSXV:CEV,OTCQX:CPXVF,FWB:XOV) announced closing of the second tranche of its non-brokered private placement financing of $1.36 million.
As quoted in the press release:
… through the sale of 1,180,213 common shares on a flow-through basis (the “Flow-Through Common Shares”) at a price of $0.35 per Flow-Through Common Share and 2,966,942 units (the “Units”) at a price of $0.32 per Unit, for gross proceeds to Cap-Ex of approximately $1.36 million… In the aggregate, the two tranches of the non-brokered private placement have resulted in gross proceeds to Cap-Ex of approximately $4.86 million.
Click here to read the Cap-Ex Ventures (TSXV:CEV,OTCQX:CPXVF,FWB:XOV) press release
Click here to see the Cap-Ex Ventures (TSXV:CEV,OTCQX:CPXVF,FWB:XOV) profile
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.